LAUSR

Low-Thrombogenicity Mechanical Heart Valves: Which Antithrombotic Strategy?

Sign Up to like & get
recommendations!
0 Published in 2018 at "Journal of the American College of Cardiology"

DOI: 10.1016/j.jacc.2018.07.065

Abstract: We read with interest the results of the PROACT (Prospective Randomized On-X Anticoagulation Trial) trial [(1)][1], which evaluated possible alternatives to standard warfarin therapy for carriers of a low-thrombogenicity mechanical heart valve (MHV). We comment… read more here.

Keywords: mechanical heart; low thrombogenicity; thrombogenicity mechanical; heart valves ... See more keywords